Pricing
Login
Home
Charts
Search
Watchlist
Products

Cohance Lifesciences Ltd

COHANCE
NSE
₹455.20-0.52%17 Nov 2026 at 1:45 PM
Reports
Pharma API

Cohance Lifesciences Ltd

COHANCE
NSE
₹455.20
-0.52%
17 Nov 2026 at 1:45 PM
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹17,394Cr
Close
Close Price
₹454.60
Industry
Industry
Pharma API
PE
Price To Earnings
366.61
PS
Price To Sales
8.43
Revenue
Revenue
₹2,063Cr
Rev Gr TTM
Revenue Growth TTM
-21.32%
PAT Gr TTM
PAT Growth TTM
-101.46%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
220253488604676840549556545619422477
Growth YoY
Revenue Growth YoY%
-37.9-31.540.4161.3207.6232.312.6-8.0-19.5-26.3-23.1-14.2
Expenses
ExpensesCr
154180363398439611437435449520421441
Operating Profit
Operating ProfitCr
66731252052372291121219599135
OPM
OPM%
30.129.025.634.035.127.320.421.817.515.90.37.4
Other Income
Other IncomeCr
1417191622-46161-181212
Interest Expense
Interest ExpenseCr
22101011101099978
Depreciation
DepreciationCr
131731384454454447515050
PBT
PBTCr
657110317420516163844120-43-11
Tax
TaxCr
191728365144161712122-13
PAT
PATCr
4753751381531174666298-452
Growth YoY
PAT Growth YoY%
-56.6-57.0-37.573.8228.3119.5-38.4-52.0-81.1-92.9-197.4-96.6
NPM
NPM%
21.321.115.422.922.713.98.411.95.31.3-10.70.5
EPS
EPS₹
1.82.12.03.64.03.21.31.91.00.5-0.60.4
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
220253488604676840549556545619422477
Growth YoY
Revenue Growth YoY%
-37.9-31.540.4161.3207.6232.312.6-8.0-19.5-26.3-23.1-14.2
Expenses
ExpensesCr
154180363398439611437435449520421441
Operating Profit
Operating ProfitCr
66731252052372291121219599135
OPM
OPM%
30.129.025.634.035.127.320.421.817.515.90.37.4
Other Income
Other IncomeCr
1417191622-46161-181212
Interest Expense
Interest ExpenseCr
22101011101099978
Depreciation
DepreciationCr
131731384454454447515050
PBT
PBTCr
657110317420516163844120-43-11
Tax
TaxCr
191728365144161712122-13
PAT
PATCr
4753751381531174666298-452
Growth YoY
PAT Growth YoY%
-56.6-57.0-37.573.8228.3119.5-38.4-52.0-81.1-92.9-197.4-96.6
NPM
NPM%
21.321.115.422.922.713.98.411.95.31.3-10.70.5
EPS
EPS₹
1.82.12.03.64.03.21.31.91.00.5-0.60.4

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
3788341,0101,3201,3401,0512,6092,2692,063
Growth
Revenue Growth%
120.721.130.81.5-21.6148.1-13.0-21.3
Expenses
ExpensesCr
2064525697417746461,8111,8421,832
Operating Profit
Operating ProfitCr
172382440579567406797427231
OPM
OPM%
45.445.843.643.942.338.630.618.811.2
Other Income
Other IncomeCr
1666813346625358
Interest Expense
Interest ExpenseCr
3209657413733
Depreciation
DepreciationCr
122432394855167187198
PBT
PBTCr
1584054686685604066432077
Tax
TaxCr
49881052141481051585712
PAT
PATCr
109317362454411300484150-6
Growth
PAT Growth%
190.114.325.2-9.4-27.061.3-69.0-101.5
NPM
NPM%
28.938.035.934.430.728.618.66.6-0.3
EPS
EPS₹
8.612.514.217.816.211.812.84.71.2
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
3788341,0101,3201,3401,0512,6092,2692,063
Growth
Revenue Growth%
120.721.130.81.5-21.6148.1-13.0-21.3
Expenses
ExpensesCr
2064525697417746461,8111,8421,832
Operating Profit
Operating ProfitCr
172382440579567406797427231
OPM
OPM%
45.445.843.643.942.338.630.618.811.2
Other Income
Other IncomeCr
1666813346625358
Interest Expense
Interest ExpenseCr
3209657413733
Depreciation
DepreciationCr
122432394855167187198
PBT
PBTCr
1584054686685604066432077
Tax
TaxCr
49881052141481051585712
PAT
PATCr
109317362454411300484150-6
Growth
PAT Growth%
190.114.325.2-9.4-27.061.3-69.0-101.5
NPM
NPM%
28.938.035.934.430.728.618.66.6-0.3
EPS
EPS₹
8.612.514.217.816.211.812.84.71.2

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
131325252525253838
Reserves
ReservesCr
5788321,1551,5021,7102,0253,6043,8733,874
Current Liabilities
Current LiabilitiesCr
158200220210159107705646865
Non Current Liabilities
Non Current LiabilitiesCr
35128749272979831,050828
Total Liabilities
Total LiabilitiesCr
7831,1731,4741,8301,9662,2545,4815,7305,680
Current Assets
Current AssetsCr
3903925651,1281,0111,2631,7581,7961,717
Non Current Assets
Non Current AssetsCr
3937819107029559913,7233,9333,939
Total Assets
Total AssetsCr
7831,1731,4741,8301,9662,2545,4815,7305,680
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
131325252525253838
Reserves
ReservesCr
5788321,1551,5021,7102,0253,6043,8733,874
Current Liabilities
Current LiabilitiesCr
158200220210159107705646865
Non Current Liabilities
Non Current LiabilitiesCr
35128749272979831,050828
Total Liabilities
Total LiabilitiesCr
7831,1731,4741,8301,9662,2545,4815,7305,680
Current Assets
Current AssetsCr
3903925651,1281,0111,2631,7581,7961,717
Non Current Assets
Non Current AssetsCr
3937819107029559913,7233,9333,939
Total Assets
Total AssetsCr
7831,1731,4741,8301,9662,2545,4815,7305,680

Cash Flow

Consolidated
Standalone
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
50407383330457358673368
Investing Cash Flow
Investing Cash FlowCr
-65-413-311-136-195-362-390-255
Financing Cash Flow
Financing Cash FlowCr
267-76-156-242-14-327-165
Net Cash Flow
Net Cash FlowCr
111-53720-18-44-51
Free Cash Flow
Free Cash FlowCr
-6304272255171307357169
CFO To PAT
CFO To PAT%
46.1128.4105.672.7111.2119.4139.1245.3
CFO To EBITDA
CFO To EBITDA%
29.4106.686.857.080.788.384.586.3
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
50407383330457358673368
Investing Cash Flow
Investing Cash FlowCr
-65-413-311-136-195-362-390-255
Financing Cash Flow
Financing Cash FlowCr
267-76-156-242-14-327-165
Net Cash Flow
Net Cash FlowCr
111-53720-18-44-51
Free Cash Flow
Free Cash FlowCr
-6304272255171307357169
CFO To PAT
CFO To PAT%
46.1128.4105.672.7111.2119.4139.1245.3
CFO To EBITDA
CFO To EBITDA%
29.4106.686.857.080.788.384.586.3

Ratios

Consolidated
Standalone
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
2,56412,61115,73112,03317,22429,52411,55017,394
Price To Earnings
Price To Earnings
8.134.834.729.357.360.664.5366.6
Price To Sales
Price To Sales
3.112.511.99.016.411.35.18.4
Price To Book
Price To Book
3.010.710.36.98.48.13.04.5
EV To EBITDA
EV To EBITDA
7.228.927.221.242.537.527.977.6
Profitability Ratios
Profitability Ratios
GPM
GPM%
59.160.156.956.656.357.356.453.053.0
OPM
OPM%
45.445.843.643.942.338.630.618.811.2
NPM
NPM%
28.938.035.934.430.728.618.66.6-0.3
ROCE
ROCE%
23.941.236.041.531.319.516.65.71.0
ROE
ROE%
18.537.530.729.723.714.613.33.8-0.1
ROA
ROA%
14.027.024.624.820.913.38.82.6-0.1
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
2,56412,61115,73112,03317,22429,52411,55017,394
Price To Earnings
Price To Earnings
8.134.834.729.357.360.664.5366.6
Price To Sales
Price To Sales
3.112.511.99.016.411.35.18.4
Price To Book
Price To Book
3.010.710.36.98.48.13.04.5
EV To EBITDA
EV To EBITDA
7.228.927.221.242.537.527.977.6
Profitability Ratios
Profitability Ratios
GPM
GPM%
59.160.156.956.656.357.356.453.053.0
OPM
OPM%
45.445.843.643.942.338.630.618.811.2
NPM
NPM%
28.938.035.934.430.728.618.66.6-0.3
ROCE
ROCE%
23.941.236.041.531.319.516.65.71.0
ROE
ROE%
18.537.530.729.723.714.613.33.8-0.1
ROA
ROA%
14.027.024.624.820.913.38.82.6-0.1
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Pharma API
Market CapitalizationMkt CapCr18,31817,71617,38611,65210,2129,1415,618
Close PriceClose₹936.601,440.70454.40556.901,589.201,008.00191.40
IndustryIndustryPharma APIPharma APIPharma APIPharma APIPharma APIPharma APIPharma API
Price To EarningsPE55.0926.42366.4541.6875.3535.6127.66
Price To SalesPS9.946.608.439.9611.754.232.04
RevenueRevenueCr1,8422,6842,0631,1708692,1612,751
Revenue Growth TTMRev Gr TTM%37.3%8.2%-21.3%4.0%13.4%26.8%
PAT Growth TTMPAT Gr TTM%142.2%26.3%-101.5%-13.6%7.1%75.4%
Market CapitalizationMkt CapCr18,31817,71617,38611,65210,2129,1415,618
Close PriceClose₹936.601,440.70454.40556.901,589.201,008.00191.40
IndustryIndustryPharma APIPharma APIPharma APIPharma APIPharma APIPharma APIPharma API
Price To EarningsPE55.0926.42366.4541.6875.3535.6127.66
Price To SalesPS9.946.608.439.9611.754.232.04
RevenueRevenueCr1,8422,6842,0631,1708692,1612,751
Revenue Growth TTMRev Gr TTM%37.3%8.2%-21.3%4.0%13.4%26.8%
PAT Growth TTMPAT Gr TTM%142.2%26.3%-101.5%-13.6%7.1%75.4%
Annual Reports
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Quarterly Reports
FY2026
Annual Reports
Quarterly Reports
Load More
Interviews